Semaglutide and Ozempic-like drugs may improve kidney disease outcomes Wed 3 Jun 2026 at 5:00am In short: New research shows people with type 2 diabetes and chronic kidney disease who took semaglutide (commonly sold as Ozempic) once a week had improved kidney outcomes, even if they had heart disease or a history of heart failure
Sign up for our free 10-week Diabetes course
Maximus programs typically range $129/mo to $349/mo
However, in a recent study by a group at UT Austin, researchers used microdialysis, which involves inserting a small catheter into the brain, to investigate the roles of GABA and glutamate during memory tasks
Common side effects include increased appetite, weight gain and sedation
As mitochondria perform oxidative phosphorylation to create energy, they inevitably leak electrons, creating ROS [1]